Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct 1:143:11-21.
doi: 10.1016/j.drugalcdep.2014.08.003. Epub 2014 Aug 17.

Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature

Kelly E Courtney  1 , Lara A Ray  2
Affiliations
Review

Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature

Kelly E Courtney et al. Drug Alcohol Depend. .

Abstract

Background: Despite initial reports of a decline in use in the early 2000s, methamphetamine remains a significant public health concern with known neurotoxic and neurocognitive effects to the user. The goal of this review is to update the literature on methamphetamine use and addiction since its assent to peak popularity in 1990s.

Methods: We first review recent epidemiological reports with a focus on methamphetamine accessibility, changes in use and disorder prevalence rates over time, and accurate estimates of the associated burden of care to the individual and society. Second, we review methamphetamine pharmacology literature with emphasis on the structural and functional neurotoxic effects associated with repeated use of the drug. Third, we briefly outline the findings on methamphetamine-related neurocognitive deficits as assessed via behavioral and neuroimaging paradigms. Lastly, we review the clinical presentation of methamphetamine addiction and the evidence supporting the available psychosocial and pharmacological treatments within the context of an addiction biology framework.

Conclusion: Taken together, this review provides a broad-based update of the available literature covering methamphetamine research over the past two decades and concludes with recommendations for future research.

Keywords: Addiction; Medication development; Methamphetamine; Stimulants.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: LAR is a paid consultant for GSK. No other conflicts of interest declared.

References

    1. Acquas E, Meloni M, Di Chiara G. Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur J Pharmacol. 1993;230:239–241. - PubMed
    1. American Psychiatric Association. Diagnostic And Statistical Manual Of Mental Disorders. American Psychiatric Association; Washington, DC: 1994.
    1. American Psychiatric Association. Diagnostic And Statistical Manual Of Mental Disorders. American Psychiatric Publishing; Arlington, VA: 2013.
    1. Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E, Kahn R, Chiang N, Beresford T, Campbell J, Haning W, Mawhinney J, McCann M, Rawson R, Stock C, Weis D, Yu E, Elkashef AM. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2012;120:135–141. - PMC - PubMed
    1. Anggadiredja K, Sakimura K, Hiranita T, Yamamoto T. Naltrexone attenuates cue-but not drug-induced methamphetamine seeking: A possible mechanism for the dissociation of primary and secondary reward. Brain Res. 2004;1021:272–276. - PubMed

Publication types

MeSH terms

Substances